Forbion Growth Opportunities Fund I Cooperatief U.A.

FollowCreate a free account to set a filing alert.

Director at Forbion European Acquisition Corp. · on record since Oct 31, 2023
10% owner at enGene Therapeutics Inc. · on record since Nov 2, 2023
10% owner at NewAmsterdam Pharma Co N.V. · on record since Jan 2, 2024
10% owner at Forbion European Acquisition Corp. · on record since Mar 18, 2022

Insider trading activity of Forbion Growth Opportunities Fund I Cooperatief U.A.

Transactions on record: 17; since Oct 31, 2023

Purchases: 13; $3M

Sales: 0

Companies traded: 2; last filing Oct 18, 2024

Figures computed from official regulatory filings — .

Companies where Forbion Growth Opportunities Fund I Cooperatief U.A. has traded

enGene Therapeutics Inc.13 tx · $3M · Oct 18, 2024
Forbion European Acquisition Corp.4 tx · Oct 31, 2023

Track record of Forbion Growth Opportunities Fund I Cooperatief U.A.

Statistical track record

Free account

Purchases: 13

Last buy: Oct 8, 2024

Win rates, median returns and the proven-insider analysis come with a free account.

Create a free account

Transaction history of Forbion Growth Opportunities Fund I Cooperatief U.A.

Co-insiders of Forbion Growth Opportunities Fund I Cooperatief U.A.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	2,750	7.17 USD	$19.7K	conv 48First in 12mo	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	5,050	7.69 USD	$38.8K	conv 38	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	10,153	6.37 USD	$64.7K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	341,332	6.34 USD	$2.2M	conv 58Unusual size	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	800	6.60 USD	$5.3K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	11,844	6.55 USD	$77.6K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	38,396	5.94 USD	$228.1K	conv 59Unusual size	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	5,997	6.54 USD	$39.2K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	35,279	6.44 USD	$227.2K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	9,620	9.09 USD	$87.4K	conv 38	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	400	8.30 USD	$3.3K	conv 38	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	3,243	6.38 USD	$20.7K	conv 35	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	5,769	6.48 USD	$37.4K	conv 29	SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	OtherD (derivative)	-731,619	—	n/a (No price was disclosed in the filing)		SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	Other	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	Other	-1,373,496	—	n/a (No price was disclosed in the filing)		SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	OtherD (derivative)	-666,666	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	2,750	7.17 USD	$19.7K	conv 48First in 12mo	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	5,050	7.69 USD	$38.8K	conv 38	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	10,153	6.37 USD	$64.7K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	341,332	6.34 USD	$2.2M	conv 58Unusual size	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	800	6.60 USD	$5.3K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	11,844	6.55 USD	$77.6K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	38,396	5.94 USD	$228.1K	conv 59Unusual size	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	5,997	6.54 USD	$39.2K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	35,279	6.44 USD	$227.2K	conv 29	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	9,620	9.09 USD	$87.4K	conv 38	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	400	8.30 USD	$3.3K	conv 38	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	3,243	6.38 USD	$20.7K	conv 35	SEC
enGene Therapeutics Inc.Listing on record	Oct 18, 2024	Buy	5,769	6.48 USD	$37.4K	conv 29	SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	OtherD (derivative)	-731,619	—	n/a (No price was disclosed in the filing)		SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	Other	-2,000,000	—	n/a (No price was disclosed in the filing)		SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	Other	-1,373,496	—	n/a (No price was disclosed in the filing)		SEC
Forbion European Acquisition Corp.Listing unverified	Oct 31, 2023	OtherD (derivative)	-666,666	—	n/a (No price was disclosed in the filing)		SEC